Jonathan B. Zung's most recent trade in Curis Inc was a trade of 135,000 Employee stock option (right to buy) done . Disclosure was reported to the exchange on May 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Curis Inc | Jonathan B. Zung | CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 135,000 | 135,000 | - | - | Employee stock option (right to buy) | |
| Curis Inc | Jonathan B. Zung | CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 15,000 | 15,000 | - | - | Employee stock option (right to buy) | |
| Curis Inc | Jonathan B. Zung | CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 40,700 | 40,700 | - | - | Employee stock option (right to buy) | |
| Evelo Biosciences Inc | Jonathan B. Zung | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Evelo Biosciences Inc | Jonathan B. Zung | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Evelo Biosciences Inc | Jonathan B. Zung | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 10,000 | 10,000 | - | - | Restricted Stock Units |